{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T06:27:15Z","timestamp":1786602435785,"version":"build-2736575974"},"reference-count":16,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2026.1959643","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T05:33:04Z","timestamp":1786599184000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Editorial: Exploring miRNA roles in neuroinflammation and brain aging: mechanisms and therapeutic potential"],"prefix":"10.3389","volume":"17","author":[{"given":"Ken-Ichiro","family":"Fukuchi","sequence":"first","affiliation":[{"name":"Department of Cancer Biology and Pharmacology, University of Illinois College of Medicine Peoria","place":["Peoria, IL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junling","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Cancer Biology and Pharmacology, University of Illinois College of Medicine Peoria","place":["Peoria, IL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Williams","sequence":"additional","affiliation":[{"name":"Department of Anatomy, University of Otago","place":["Dunedin, New Zealand"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.821225","article-title":"NLRP3 inflammasome-dependent pyroptosis in CNS trauma: A potential therapeutic target","volume":"10","author":"Zhou","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2022.949939","article-title":"Pyroptosis in spinal cord injury","volume":"16","author":"Yin","year":"2022","journal-title":"Front Cell Neurosci"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1177\/0963689720939131","article-title":"MiR-128-3p post-transcriptionally inhibits WISP1 to suppress apoptosis and inflammation in human articular chondrocytes via the PI3K\/AKT\/NF-kappaB signaling pathway","volume":"29","author":"Chen","year":"2020","journal-title":"Cell Transplant"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.12659\/msm.898788","article-title":"Down-regulation of miRNA-128 contributes to neuropathic pain following spinal cord injury via activation of P38","volume":"23","author":"Yang","year":"2017","journal-title":"Med Sci Monit"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2012.03.018","article-title":"MiR-34a inhibits lipopolysaccharide-induced inflammatory response through targeting Notch1 in murine macrophages","volume":"318","author":"Jiang","year":"2012","journal-title":"Exp Cell Res"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2016.05.026","article-title":"Expression of microRNA-34a in Alzheimer's disease brain targets genes linked to synaptic plasticity, energy metabolism, and resting state network activity","volume":"1646","author":"Sarkar","year":"2016","journal-title":"Brain Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2174\/1389450115666140120102935","article-title":"MicroRNA-34a: Role in cancer and cardiovascular disease","volume":"15","author":"Chen","year":"2014","journal-title":"Curr Drug Targets"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12135","article-title":"Elevated microRNA-34a in obesity reduces NAD+ levels and SIRT1 activity by directly targeting NAMPT","volume":"12","author":"Choi","year":"2013","journal-title":"Aging Cell"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2025.108217","article-title":"Dementia prevention, intervention, and care: Comments on the 2024 report of the Lancet standing Commission","volume":"195","author":"Depypere","year":"2025","journal-title":"Maturitas"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e1442","article-title":"Inverse association between cancer and Alzheimer's disease: Results from the Framingham Heart Study","volume":"344","author":"Driver","year":"2012","journal-title":"BMJ"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-140168","article-title":"Association between cancer and Alzheimer's disease: Systematic review and meta-analysis","volume":"42","author":"Ma","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"985","DOI":"10.18632\/aging.100371","article-title":"Circulatory miR34a as an RNAbased, noninvasive biomarker for brain aging","volume":"3","author":"Li","year":"2011","journal-title":"Aging (Albany NY)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-016-0088-8","article-title":"Plasma miR-34a-5p and miR-545-3p as early biomarkers of Alzheimer's disease: Potential and limitations","volume":"54","author":"Cosin-Tomas","year":"2017","journal-title":"Mol Neurobiol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/emboj.2010.211","article-title":"Neurotoxicity of Alzheimer's disease Abeta peptides is induced by small changes in the Abeta42 to Abeta40 ratio","volume":"29","author":"Kuperstein","year":"2010","journal-title":"EMBO J"},{"key":"B15","doi-asserted-by":"publisher","first-page":"14293","DOI":"10.1038\/s41598-017-14301-3","article-title":"Exosomal microRNA signatures in multiple sclerosis reflect disease status","volume":"7","author":"Ebrahimkhani","year":"2017","journal-title":"Sci Rep"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114593","article-title":"Mesenchymal stem cell-derived exosomal microRNA-367-3p alleviates experimental autoimmune encephalomyelitis via inhibition of microglial ferroptosis by targeting EZH2","volume":"162","author":"Fan","year":"2023","journal-title":"BioMed Pharmacother"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1959643\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T05:33:05Z","timestamp":1786599185000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1959643\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":16,"alternative-id":["10.3389\/fimmu.2026.1959643"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1959643","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]},"article-number":"1959643"}}